R&D channel feed – Endpoints News

R&D channel feed

Gilead expands its big bet on Arcus, moving into inflammation in large new collaboration

3 years ago

Still under clinical hold, Fulcrum locks in seasoned commercial leader as CEO

3 years ago

CVS will shut down clinical trials unit that it launched during Covid

3 years ago

Proxy adviser ISS supports only one of Icahn's candidates for Illumina board

3 years ago

FDA adcomm backs accelerated approval of Sarepta's Duchenne gene therapy in close vote

3 years ago

Gracell gives sneak peek into leukemia CAR-T cell program ahead of EHA

3 years ago

Amylyx's Relyvrio pulls in $71M in revenue

3 years ago

In preliminary readout, GSK notches win for meningococcal vaccine

3 years ago

Innovent showcases topline PhII win for high-dose obesity drug in China

3 years ago

Italy's Angelini Pharma teams up with JCR on blood-brain barrier deal

3 years ago

Olema gives small update to breast cancer drug at center of layoffs, 2021 data leak

3 years ago

BioNTech and Matinas end oral mRNA delivery collaboration

3 years ago

Takeda winds down Theravance pact, culls partnered Crohn's program after PhII flops

3 years ago

FDA rejects bladder cancer therapy developed by Patrick Soon-Shiong’s ImmunityBio

3 years ago

Reata culls bardoxolone, ending decade of R&D on troubled kidney disease drug

3 years ago

Boehringer brings early data for GLP-1 receptor showing almost 15% weight loss after 46 weeks

3 years ago

When orphan drugs are blockbusters: Researchers call on Congress to make companies pay back tax credits

3 years ago

As Zynlonta sales disappoint, ADC Therapeutics cuts staff and preclinical programs

3 years ago

FDA lifts partial hold on Salarius' Ewing sarcoma drug trial

3 years ago

Updated: EQRx abandons its mission of drug price reform, will cut more than half of employees

3 years ago

Lundbeck out-licenses three candidates to Cambridge biotech

3 years ago

After Rubius collapse and brief stop at Flagship startup, Pablo Cagnoni finds new start at Incyte

3 years ago

When is a preclinical drug worth a mother lode of cash? This top 20 list offers a few answers

3 years ago

Nonhuman primate shortage worsens due to pandemic, importation challenges — study

3 years ago

First page Previous page 87 88 899091 92 93 Next page Last page